HomeBusinessGlobal EconomyAstraZeneca’s CEO Is Willing to Compromise — When It’s for TrumpAstraZeneca’s CEO Is Willing to Compromise — When It’s for Trump November 5, 2025nileshsha@hotmail.com Pascal Soriot has turned the drugmaker into an oncology powerhouse with a high-pressure culture and a deep relationship with the US. www.bloomberg.com #AstraZenecas #CEO #Compromise #ampmdash #TrumpRelated reading:Can Farage’s Reform Conquer England? This Town Is a ClueToto Shares Surge on Plans to Boost Chip Parts BusinessApple Earnings, Trump Nominates Saphier for Surgeon GeneralShare: X · Facebook · LinkedIn
UK Plans New Measure to Boost EV Sales, Transport Secretary SaysThe UK plans to introduce new incentives to make it cheaper for people to buy new electric vehicles as the…
Zelenskiy Tacks Close to European Allies as Witkoff heads to RussiaUkraine’s Volodymyr Zelenskiy meets Macron at start of crucial week for Ukraine www.bloomberg.com #Zelenskiy #Tacks #Close #European #Allies #Witkoff #heads…
Reasonable to be Optimistic About Markets in 2026, Says Rick GardnerRick Gardner, CIO of RGA Investments, breaks down his outlook heading into the new year. Garnder says that its reasonable…